Neurologic Disorder Clinical Trial
Official title:
Use of Long Read Genome Sequencing in Patients Suffering From Neurodevelopmental Troubles
Patients with neurodevelopmental diseases and their families need to identify the genetic cause of the disease to allow for recognition of the disability, genetic counseling, and possible hope for participation in therapeutic research studies. Access to high-throughput genomic exome or genome analysis allows the identification of a genetic cause for approximately half of the patients. However, families with no result or with a variant of unknown significance after these tests may find themselves in a new diagnostic impasse. The high-throughput sequencing used today generates sequences of the order of 100 base pairs (so-called "short read" sequencing). This allows an analysis of about 90% of the genome. However, many regions are not accessible in regions of interest for the genetic diagnosis of rare diseases. Long fragment sequencing generates sequences that are about 20 times larger and its use has recently made it possible to sequence the human genome almost completely (https://www.science.org/doi/10.1126/science.abj6987). The main contribution lies in the analysis of complex regions of the genome such as segmental duplications or centromeric regions. It is likely that this technology increases the sensitivity of detection of genetic variants in patients with genetic diseases. Its contribution should be studied in patients for whom no genetic cause has been identified by classical techniques. This study aim to investigate the contribution of long fragment genome sequencing.
Ten families with a child suffering from a neurodevelopmental disease will be recruited by geneticists being part of the CLAD-Ouest. An EDTA blood sample will be taken from the patient and their parents (trio analysis). The blood samples will then be used to extract nucleic acids (DNA). The blood samples will be sent and centralized to the genetics laboratory of the Nantes University Hospital. The DNA will be extracted and anonymized. The files generated after DNA sequencing will have as an identification key the anonymization number provided at the time of inclusion of the individual in the study. The raw data and VCF files will be uploaded to the BIRD computing cluster in Nantes, where they will be stored for the duration of the study (2 years). The different university hospitals will then be able to retrieve the data and analyze the variants identified in the patients recruited by their center. A centralized analysis to annotate, filter and interpret the variants will be performed by a group of bioinformaticians and biologists from HUGO (University Hospital from the Grand Ouest). Long-term archiving of the data will be performed at the Nantes University Hospital. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05519592 -
Proximal Lower Limb Intramuscular Block : Effects on Hemiparetic Gait
|
N/A | |
Recruiting |
NCT04098679 -
Childhood Adiposity and Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes (CONCEPTT Kids)
|
||
Completed |
NCT03946137 -
Chest Therapy and Postural Education in Children With Cerebral Palsy
|
N/A | |
Completed |
NCT05217186 -
Associations Between Early Neonatal Neuroimaging, Hammersmith Infant Neurological Examination and General Movements
|
||
Not yet recruiting |
NCT05506306 -
Multitissular Effect of Vertical Mobilization Using the Exoskeleton AtalanteTM in Neurological Chair- or Bed-bound Patients
|
||
Recruiting |
NCT04846413 -
Voice Analysis in Patients With Neurologic Diseases
|
||
Recruiting |
NCT05260190 -
Manual Dexterity Modifications After Application of tSMS Over the Primary Motor Cortex (M1)
|
N/A | |
Not yet recruiting |
NCT04906681 -
Implementation of a Rehabilitation Technology in Orthopedic and Neurological Rehabilitation to Increase Therapy Dosage: an Exploratory Study
|
Phase 1/Phase 2 | |
Completed |
NCT04743037 -
Interactive Self-Management Augmented by Rehabilitation Technologies
|
N/A | |
Not yet recruiting |
NCT03899298 -
Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions
|
Phase 1 | |
Active, not recruiting |
NCT04631965 -
Healthcare Transition of Adolescents With Chronic Health Conditions
|
||
Recruiting |
NCT05132517 -
Magnesium and Cognition After Stroke
|
||
Recruiting |
NCT04100993 -
Multisystem and Autonomic Complications of NMD on Long-term NIV
|
||
Recruiting |
NCT05652946 -
IISART (International Industry Society of Advanced Rehabilitation Technology) Advanced Rehabilitation Technology Study
|
N/A | |
Recruiting |
NCT06146543 -
Stress Ball During Lumbar Puncture the Effect of the Application on Anxiety Level
|
N/A | |
Completed |
NCT06368024 -
Establishment of Delphi-MD Safety Performance and Reliability
|
||
Not yet recruiting |
NCT06169696 -
EMPOWER Early Feasibility Study: Non-invasive BCI to Control a Wheelchair for People With Paralysis
|
N/A | |
Completed |
NCT03329872 -
Neuro-Orthopedic Registry of the University Hospital of Toulouse
|
||
Completed |
NCT05483244 -
Weaning Success in Different Weaning Strategies in Early Neurological Rehabilitation Patients - a Matched-pair Analysis
|
||
Completed |
NCT04170985 -
NeuroSeq: A Prospective Trial to Evaluate the Diagnostic Yield of Whole Genome Sequencing (WGS) in Adult Neurology
|